Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021.

ABSTRACT:

Objectives

This study aimed to examine the size and trends in payments from the pharmaceutical industry to healthcare professional organisations (HPOs) in the United Kingdom (UK), and to characterise the conflict of interest (COI) management plans by HPOs who received large payments.

Design

Cross-sectional analysis of non-research payments disclosed in the Disclosure UK database from 2015 to 2021.

Setting

United Kingdom.

Participants

148 pharmaceutical companies disclosing payment data and HPOs receiving the largest payments.

Main outcome measures

Total value and median of payments per HPO; existence and content of COI policies among HPOs receiving the largest payments.

Results

A total of 898 HPOs received non-research payments worth £99.9 million

SUBMITTER: Murayama A 

PROVIDER: S-EPMC11574929 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature